טוען...
Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice
Patients with sickle cell disease (SCD) can have recurrent episodes of vaso-occlusive crises, which are associated with severe pain. While opioids are the mainstay of analgesic therapy, in some patients, increasing opioid use results in continued and increasing pain. Many believe that this phenomeno...
שמור ב:
| הוצא לאור ב: | Eur J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4397100/ https://ncbi.nlm.nih.gov/pubmed/25724786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2015.02.027 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|